Charles Theuer | President and Chief Executive Officer |
Scott Brown | Chief Accounting Officer and Head of Finance |
Maury Raycroft | Jefferies |
Ed White | H.C. Wainwright |
Jim Molloy | Alliance Global Partners |
Nicholas Abbott | Wells Fargo |
Bert Hazlett | BTIG |
Good day, ladies and gentlemen, and welcome to the TRACON Pharmaceuticals First Quarter 2020 Earnings Conference Call. [Operator Instructions]
During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway and our development plans and strategy. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2019, and subsequent quarterly reports on Form 10-Q.
You are cautioned not to place undue reliance on these forward-looking statements, and we disclaim any obligation to update such statements.